Risk factors of mortality for nosocomial pneumonia: importance of initial anti-microbial therapy

被引:23
作者
Lee, SC
Hua, CC
Yu, TJ
Shieh, WB
See, LC
机构
[1] Chang Gung Mem Hosp, Div Infect Dis, Dept Chest, Chilung 204, Taiwan
[2] Chang Gung Univ, Dept Publ Hlth, Linkou, Taiwan
关键词
anti-microbial therapy; nosocomial pneumonia; risk factors;
D O I
10.1111/j.1742-1241.2005.00281.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nosocomial pneumonia is a common nosocomial infection and has high mortality rate. Risk factors of mortality of nosocomial pneumonia were studied in 132 hospitalised patients who developed nosocomial pneumonia. The overall mortality rate was 64/132, 48.5%. Of the 11 risk factors univariately associated with mortality due to nosocomial pneumonia, only the inappropriate initial anti-microbial therapy, high simplified acute physiology score and multiple organ failures remained significant after stepwise logistic regression. Gram-negative bacilli were still the most pre-dominant causative microbiologic agents of nosocomial pneumonia with Pseudomonas aeruginosa (20.3%), Acineto-bacter baumannii (18.6%) and Escherichia coli (5.9%) being the three most predominant pathogens. A. baumannii were significantly more predominant among non-survivors than survivors (13.56 vs. 5.08%, p = 0.0418). The incidence rate of methicillin-resistant Staphylococcus aureus was 19.5% higher than previous reports. We conclude that inappropriate initial anti-microbial therapy for nosocomial pneumonia is associated with the mortality rate of nosocomial pneumonia, and appropriate anti-microbial therapy improves outcome of nosocomial pneumonia. (C) 2005 Blackwell Publishing Ltd.
引用
收藏
页码:39 / 45
页数:7
相关论文
共 31 条
[11]   NOSOCOMIAL PNEUMONIA IN PATIENTS RECEIVING CONTINUOUS MECHANICAL VENTILATION - PROSPECTIVE ANALYSIS OF 52 EPISODES WITH USE OF A PROTECTED SPECIMEN BRUSH AND QUANTITATIVE CULTURE TECHNIQUES [J].
FAGON, JY ;
CHASTRE, J ;
DOMART, Y ;
TROUILLET, JL ;
PIERRE, J ;
DARNE, C ;
GIBERT, C .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 139 (04) :877-884
[12]  
GILBERT DN, 2001, GUIDE ANTIMICROBIOL, P26
[13]  
GRAYBILL JR, 1973, AM REV RESPIR DIS, V108, P18
[14]  
GREENAWAY CA, 1997, INFECT CONT HOSP EP, P749
[15]  
Infectious Diseases Society of the Republic of China, 2000, J MICROBIOL IMMUNOL, V33, P271
[16]   Etiology of community-acquired pneumonia in hospitalized patients - A 3-year prospective study in Japan [J].
Ishida, T ;
Hashimoto, T ;
Arita, M ;
Ito, I ;
Osawa, M .
CHEST, 1998, 114 (06) :1588-1593
[17]  
JENNETT B, 1976, LANCET, V1, P1031
[18]   INCIDENCE AND ETIOLOGY OF PNEUMONIA ACQUIRED DURING MECHANICAL VENTILATION [J].
JIMENEZ, P ;
TORRES, A ;
RODRIGUEZROISIN, R ;
DELABELLACASA, JP ;
AZNAR, R ;
GATELL, JM ;
AGUSTIVIDAL, A .
CRITICAL CARE MEDICINE, 1989, 17 (09) :882-885
[19]   Usefulness of quantitative cultures of BAL fluid for diagnosing nosocomial pneumonia in ventilated patients [J].
Jourdain, B ;
JolyGuillou, ML ;
Dombret, MC ;
Calvat, S ;
Trouillet, JL ;
Gibert, C ;
Chastre, J .
CHEST, 1997, 111 (02) :411-418
[20]   THE EFFECT OF LATE-ONSET VENTILATOR-ASSOCIATED PNEUMONIA IN DETERMINING PATIENT MORTALITY [J].
KOLLEF, MH ;
SILVER, P ;
MURPHY, DM ;
TROVILLION, E .
CHEST, 1995, 108 (06) :1655-1662